All lobbying filings

Forbes-Tate

Forbes-Tate filed a Q3 termination report for Bio-RAD Laboratories on September 2, 2026, reporting $20,000 in lobbying income.

Lobbying for Bio-RAD Laboratories · Life sciences biomedical diagnostic innovator.

As filed: FORBES-TATE for BIO-RAD LABORATORIES.

All filings by Forbes-Tate · Everything Bio-RAD Laboratories has reported

Filing · LD-2 quarterly report Q3 termination

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Sep 2, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

California

Representation ended

Jul 27, 2026

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medicare/Medicaid

Issues related to advanced diagnostic testing and laboratory tools.

Health Issues

Issues related to biomedical research and development; Issues related to pathogen surveillance.

Defense

Issues related to biomedical research and development; Issues related to pathogen surveillance.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.